Wang, Hung-Ming

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Burtness, B., Harrington, K. J., Greil, R., Soulières, D., Tahara, M., de Castro, G., Psyrri, A., Basté, N., Neupane, P., Bratland, Å., et al. (2019) · The Lancet

Head and Neck Cancer StudiesCancer Immunotherapy and Biomarkers

Cited by 3,336

Isolation of label-free and viable circulating tumour cells (CTCs) from blood samples of cancer patients through a two-step process: negative selection-type immunomagnetic beads and spheroid cell culture-based cell isolation

Liao, C.-J., Hsieh, C.-H., Wang, H.-M., Chou, W.-P., Chiu, T.-K., Chang, J.-H., Chao, A.-C., & Wu, M.-H. (2017) · RSC Advances

Microfluidic and Bio-sensing TechnologiesCancer Cells and Metastasis

Cited by 20